MDT Services & Technologies SRL
The score of MDT Services & Technologies shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -38 % Total assets -64 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
MDT Services & Technologies's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Aug 2026
- Year ended 31 Dec 2024filed on 25 Aug 2025
- Year ended 31 Dec 2023filed on 28 Aug 2024
- Year ended 31 Dec 2022filed on 14 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
MDT Services & Technologies's financial analysis
- Solvency66.6%sector median: 38.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of MDT Services & Technologies
MDT Services & Technologies's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0544.556.812
- VAT number
- BE0544556812
- Peppol
- Registered · 0208:0544556812 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Jan 2014
- Registered office
- 4710 Lontzen
- Latest accounts
- 2025 · filed on 10 Aug 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
MDT Services & Technologies (SRL) has been based in Lontzen since 2014, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net loss of 32 € and equity of 68,160 €; its revenue is not published. Its solvency stands at 66.6%, above the median of its sector (38.7%).
Companies similar to MDT Services & Technologies
Companies in the same business, of comparable size and area, outside its group.
- huMAN Manufacture of basic pharmaceutical products Gerpinnes · balance sheet 186,227 €
- MyCombiLab Manufacture of pharmaceutical preparations Antwerp · balance sheet 66,138 €
- Yaro Preclinical Consulting Manufacture of basic pharmaceutical products Turnhout · balance sheet 158,481 €
- Medipharm Worldwide Group Manufacture of basic pharmaceutical products Tienen · balance sheet 331,081 €
- Pneoo Business and other management consultancy activities Vosselaar · balance sheet 145,836 €
- Regen Consulting Manufacture of basic pharmaceutical products Chaumont-Gistoux · balance sheet 104,347 €
- QP Pro Services Manufacture of basic pharmaceutical products Gembloux · balance sheet 304,804 €
- Fytobell Manufacture of pharmaceutical preparations Hasselt · balance sheet 122,152 €
Frequently asked questions about MDT Services & Technologies
What is the revenue of MDT Services & Technologies?
MDT Services & Technologies files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of MDT Services & Technologies?
In Belgium, the VAT number is the company number prefixed with BE: BE0544556812 for MDT Services & Technologies, if the company is VAT-registered. Its company number (CBE) is 0544.556.812.
Where is the registered office of MDT Services & Technologies?
According to the CBE register, the registered office of MDT Services & Technologies is in 4710 Lontzen.
What is the equity of MDT Services & Technologies?
At the close of the 2025 financial year, the equity of MDT Services & Technologies amounts to 68,160 €, a solvency of 66.6% of total assets.
Who manages MDT Services & Technologies?
The register lists 1 active mandates at MDT Services & Technologies. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of MDT Services & Technologies
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →